This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: National Health Research Institutes, Regents of the University of Minnesota. Active years: 2017-2020.
Location History:
- Zhunan, TW (2017)
- Miaoli County, TW (2020)
Company Filing History:
3 out of 189 
2 out of 2,369 
Years Active: 2017-2020
Title: The Innovative Contributions of Shau-Hua Ueng
Introduction
Shau-Hua Ueng is a notable inventor based in Miaoli County, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating opioid receptor-associated conditions. With a total of 3 patents to his name, Ueng's work has the potential to impact medical treatments significantly.
Latest Patents
Ueng's latest patents include innovative compounds such as tetrahydroisoquinolines, which are designed for use as MOR/NOP dual agonists. These compounds are detailed in a formula that includes various defined variables, and they are aimed at treating conditions associated with opioid receptors. Another significant patent involves thiazolidinone compounds, which also target opioid receptor-associated conditions. This patent outlines a pharmaceutical composition containing these compounds and methods for their application in treatment.
Career Highlights
Throughout his career, Ueng has worked with esteemed organizations such as the National Health Research Institutes and the University of Minnesota. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Ueng has collaborated with notable colleagues, including Shiu-Hwa Yeh and Chuan Shih. These partnerships have further enhanced his research and development efforts in the pharmaceutical domain.
Conclusion
Shau-Hua Ueng's innovative work in developing compounds for treating opioid receptor-associated conditions showcases his dedication to advancing medical science. His contributions through his patents reflect a commitment to improving healthcare outcomes.